154 related articles for article (PubMed ID: 25909138)
1. [Squamous cell carcinoma (SCC)--nature and usage in patients with cervical carcinoma].
Bocheva Y; Bochev P; Chaushev B; Ivanov S
Akush Ginekol (Sofiia); 2015; 54(2):29-34. PubMed ID: 25909138
[TBL] [Abstract][Full Text] [Related]
2. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
[TBL] [Abstract][Full Text] [Related]
6. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
Geyer H; Schwörer D; Pfleiderer A
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
[TBL] [Abstract][Full Text] [Related]
7. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
[TBL] [Abstract][Full Text] [Related]
8. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
[TBL] [Abstract][Full Text] [Related]
9. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
Ogino I; Nakayama H; Kitamura T; Okamoto N; Inoue T
Int J Gynecol Cancer; 2005; 15(4):630-8. PubMed ID: 16014117
[TBL] [Abstract][Full Text] [Related]
10. [The clinical usefulness of SCC antigen for diagnosis of recurrent cervical squamous cancer].
Umezawa S; Takeshima N; Shimizu Y; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):165-8. PubMed ID: 7706858
[No Abstract] [Full Text] [Related]
11. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
Chan YM; Ng TY; Ngan HY; Wong LC
Gynecol Oncol; 2002 Jan; 84(1):7-11. PubMed ID: 11748969
[TBL] [Abstract][Full Text] [Related]
12. [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].
Koch T; Eiffert H; Spindler MB
HNO; 1989 Nov; 37(11):454-9. PubMed ID: 2584067
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of SCC antigen in patients with advanced cervix cancer treated with radiation].
Roszak A; Bratos K; Górny A; Mackiewicz A
Ginekol Pol; 1996 Sep; 67(9):457-9. PubMed ID: 9289466
[TBL] [Abstract][Full Text] [Related]
14. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
Ievleva ES; Ermoshina NV; Ageenko AI
Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
[TBL] [Abstract][Full Text] [Related]
15. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
Forni F; Ferrandina G; Deodato F; Macchia G; Morganti AG; Smaniotto D; Luzi S; D'Agostino G; Valentini V; Cellini N; Giardina B; Scambia G
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1145-9. PubMed ID: 17689030
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
Luan XM; Zhang Y; Wang SZ; Wang N; Li W; Zhang Q; Wei H; Zhang SL
Zhonghua Yi Xue Za Zhi; 2012 May; 92(19):1330-3. PubMed ID: 22883121
[TBL] [Abstract][Full Text] [Related]
18. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
Rose PG; Baker S; Fournier L; Nelson BE; Hunter RE
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
[TBL] [Abstract][Full Text] [Related]
19. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.
Charakorn C; Thadanipon K; Chaijindaratana S; Rattanasiri S; Numthavaj P; Thakkinstian A
Gynecol Oncol; 2018 Jul; 150(1):190-200. PubMed ID: 29606483
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
Gocze PM; Vahrson HW; Freeman DA
Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]